World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
98
Citations
32309
World Ranking
8974
National Ranking
309

Overview

Carlo Pozzilli is affiliated with Sapienza University of Rome in Italy. Their research work primarily focuses on multiple sclerosis and related neurological disorders, with a significant number of publications in the field of medicine.

The main fields of study for Carlo Pozzilli include:

  • Medicine

Within this broad field, their subfields of research cover:

  • Pathology and Forensic Medicine
  • Neurology
  • Oncology
  • Rheumatology
  • Molecular Biology

The central topics explored in their work encompass:

  • Multiple Sclerosis Research Studies
  • Peripheral Neuropathies and Disorders
  • Polyomavirus and related diseases
  • Rheumatoid Arthritis Research and Therapies
  • Immunotherapy and Immune Responses
  • Acute Lymphoblastic Leukemia research
  • Autoimmune and Inflammatory Disorders Research

Carlo Pozzilli's frequent co-authors reveal a collaborative research environment and include:

  • Massimo Filippi
  • Francesco Patti
  • Antonio Ianniello
  • María Trojano
  • Maria Pia Amato

Their most common publication venues, indicating where a significant portion of their research has appeared, are:

  • Journal of Neurology
  • Neurology
  • Multiple Sclerosis Journal
  • Multiple Sclerosis and Related Disorders
  • Journal of Neurology Neurosurgery & Psychiatry

Among recent papers, several notable publications include:

  • Ponesimod Compared With Teriflunomide in Patients With Relapsing Multiple Sclerosis in the Active-Comparator Phase 3 OPTIMUM Study (2021), JAMA Neurology
  • Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion (2022), Journal of Neurology
  • Ravulizumab in Aquaporin-4-Positive Neuromyelitis Optica Spectrum Disorder (2023), Annals of Neurology
  • Long-term disability trajectories in relapsing multiple sclerosis patients treated with early intensive or escalation treatment strategies (2021), Therapeutic Advances in Neurological Disorders
  • Safety and efficacy of MD1003 (high-dose biotin) in patients with progressive multiple sclerosis (SPI2): a randomised, double-blind, placebo-controlled, phase 3 trial (2020), The Lancet Neurology

Best Publications

  • Defining the clinical course of multiple sclerosis: The 2013 revisions

    Fred D. Lublin;Stephen C. Reingold;Jeffrey A. Cohen;Gary R. Cutter

  • Regional cerebral oxygen supply and utilization in dementia. A clinical and physiological study with oxygen-15 and positron tomography.

    R. S J Frackowiak;C. Pozzilli;N. J. Legg;G. H. Du Boulay

  • Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo- controlled, randomized phase II trial

    Ludwig Kappos;Giancarlo Comi;Hillel Panitch;Joel Oger

  • A randomized, double-blind, placebo-controlled, parallel-group, enriched-design study of nabiximols* (Sativex®), as add-on therapy, in subjects with refractory spasticity caused by multiple sclerosis

    A. Novotna;J. Mares;S. Ratcliffe;I. Novakova

  • Diffusion-weighted imaging tractography-based parcellation of the human lateral premotor cortex identifies dorsal and ventral subregions with anatomical and functional specializations.

    Valentina Tomassini;Saad Jbabdi;Johannes C. Klein;Timothy E. J. Behrens

  • Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring

    Ludwig Kappos;David Bates;Gilles Edan;Mefkûre Eraksoy

  • Multiple sclerosis in childhood: clinical features of 149 cases.

    A. Ghezzi;V. Deplano;J. Faroni;MG Grasso

  • fMRI evidence of brain reorganization during attention and memory tasks in multiple sclerosis.

    Caterina Mainero;Francesca Caramia;Carlo Pozzilli;Angela Pisani

  • Randomized placebo-controlled trial of mitoxantrone in relapsing-remitting multiple sclerosis: 24-month clinical and MRI outcome

    E Millefiorini;C Gasperini;C Pozzilli;F D'Andrea

  • Cognitive and psychosocial features of childhood and juvenile MS

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • Progressing Neurological Deficit Secondary to Acute Ischemic Stroke: A Study on Predictability, Pathogenesis, and Prognosis

    Danilo Toni;Marco Fiorelli;Mara Gentile;Stefano Bastianello

  • The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis

    Pd Molyneux;L Kappos;C Polman;C Pozzilli

  • Assessing walking disability in multiple sclerosis

    Bernd C. Kieseier;Carlo Pozzilli

  • Guidelines on use of anti-IFN-beta antibody measurements in multiple sclerosis: report of an EFNS Task Force on IFN-beta antibodies in multiple sclerosis

    P. S. Sørensen;F. Deisenhammer;P. Duda;R. Hohlfeld

  • Interferon beta-1b in secondary progressive MS - A combined analysis of the two trials

    Ludwig Kappos;B. Weinshenker;C. Pozzilli;A. J. Thompson

  • Cognitive and psychosocial features in childhood and juvenile MS Two-year follow-up

    M. P. Amato;B. Goretti;A. Ghezzi;S. Lori

  • A mechanism-based classification of pain in multiple sclerosis.

    A. Truini;P. Barbanti;C. Pozzilli;G. Cruccu

  • Cortical motor reorganization after a single clinical attack of multiple sclerosis

    Patrizia Pantano;Gian Domenico Iannetti;Francesca Caramia;Caterina Mainero

  • Fatigue in MS is associated with specific clinical features.

    C. Colosimo;E. Millefiorini;M. G. Grasso;F. Vinci

  • Intravenous immunoglobulin in secondary progressive multiple sclerosis: randomised placebo-controlled trial

    Otto R Hommes;Per S Sørensen;Franz Fazekas;Monika Maas Enriquez

Frequent Co-Authors

Maria Trojano
Maria Trojano University of Bari Aldo Moro
Maria Pia Amato
Maria Pia Amato University of Florence
Giancarlo Comi
Giancarlo Comi Vita-Salute San Raffaele University
Massimo Filippi
Massimo Filippi Vita-Salute San Raffaele University
Diego Centonze
Diego Centonze University of Rome Tor Vergata
Eva Havrdova
Eva Havrdova Charles University
Ludwig Kappos
Ludwig Kappos University Hospital of Basel
Xavier Montalban
Xavier Montalban Autonomous University of Barcelona
Vincenzo Morra
Vincenzo Morra University of Naples Federico II
Patrick Vermersch
Patrick Vermersch University of Lille

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Medicine in the USA opens up a wide range of allied health and management career options. For those interested in hospital operations or leadership, earning a healthcare administration degree online offers the flexibility to build skills in management, finance, and policy while balancing other commitments.

Nursing professionals looking to advance can take advantage of asn to np pathways. These bridge programs help nurses move from an associate’s degree to a nurse practitioner role, often through accelerated and fully online options.

Nutrition and wellness are also growing fields within healthcare. Earning a nutritionist online degree prepares students to work in clinical, community, or private practice settings focused on diet, health, and lifestyle management.

If you are seeking leadership roles in health systems, consider the range of online mha programs cahme accredited, which ensure a high standard of curriculum recognized nationwide.

Best Scientists Citing Carlo Pozzilli

Trending Scientists

Recently Published Articles